IDXX logo

IDEXX Laboratories Inc. (IDXX)

$704.20

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IDXX

Market cap

$56.23B

EPS

12.61

P/E ratio

58.6

Price to sales

13.93

Dividend yield

--

Beta

1.667982

Price on IDXX

Previous close

$707.50

Today's open

$710.46

Day's range

$697.26 - $715.19

52 week range

$356.14 - $769.98

Profile about IDXX

CEO

Jonathan J. Mazelsky

Employees

11000

Headquarters

Westbrook, ME

Exchange

Nasdaq Global Select

Shares outstanding

79851330

Issue type

Common Stock

IDXX industries and sectors

Healthcare

Medical Diagnostics & Screening

News on IDXX

IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?

IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.

news source

Zacks Investment Research • Dec 4, 2025

news preview

Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue?

Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?

news source

Zacks Investment Research • Dec 3, 2025

news preview

What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?

Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.

news source

Zacks Investment Research • Nov 28, 2025

news preview

Idexx (IDXX) Upgraded to Buy: Here's What You Should Know

Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news source

Zacks Investment Research • Nov 28, 2025

news preview

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may be a clearer winner.

news source

Forbes • Nov 24, 2025

news preview

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)

Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

news source

Zacks Investment Research • Nov 21, 2025

news preview

Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average

From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.

news source

Zacks Investment Research • Nov 20, 2025

news preview

Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up

The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.

news source

24/7 Wall Street • Nov 14, 2025

news preview

Baron Asset Fund Q3 2025 Performance Review

Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT and Communication Services was responsible for about three-quarters of the underperformance in the period. Stock selection in Consumer Discretionary, Financials, and Industrials hampered relative results.

news source

Seeking Alpha • Nov 13, 2025

news preview

November Is The Best Month — And 5 Stocks Are Already On Fire

No single month beats November for S&P 500 stock market performance. And a handful of stocks are already taking off.

news source

Investors Business Daily • Nov 6, 2025

news preview

¹ Disclosures

Get started with M1

Invest in IDEXX Laboratories Inc.

Open an M1 investment account to buy and sell IDEXX Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IDXX on M1